NCT01491542View on ClinicalTrials.gov

INFUSE® Bone Graft and MASTERGRAFT® Granules With CD HORIZON® for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease - Pilot Study

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

March 31, 2007

Conditions
Degenerative Disc Disease
Interventions
DEVICE

INFUSE® Bone Graft/MASTERGRAFT® Granules/CD HORIZON®

The INFUSE® Bone Graft component of the investigational device consists of recombinant human Bone Morphogenetic Protein-2(rhBMP-2) and an absorbable collagen sponge (ACS)carrier. The MASTERGRAFT® Granules will be used as a type of bulking agent to provide compression resistance.

DEVICE

Autogenous Bone / CD HORIZON® Spinal System

The control will be autogenous bone taken from the iliac crest of the patient and placed bilaterally across two adjacent transverse processes and used in conjunction with the CD HORIZON® Spinal System.

All Listed Sponsors
lead

Medtronic Spinal and Biologics

INDUSTRY

NCT01491542 - INFUSE® Bone Graft and MASTERGRAFT® Granules With CD HORIZON® for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease - Pilot Study | Biotech Hunter | Biotech Hunter